Has Amy Musiek, MD received payments from drug or device companies?

Yes. Drug and device makers reported $25,138 in general payments to Amy Musiek, MD across 40 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amy Musiek, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amy Musiek, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amy Musiek, MD

Dermatology · Saint Louis, MONPI 1073660957

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,480 of the $25,138 with a category attached, or 81.5%. Kyowa Kirin, Inc. accounts for 69.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $22,784 and has fallen 91.9% since, to $1,852 in 2025. Among dermatology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,138in general payments, 2019–2025

Across 40 payments — averaging $628.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Kyowa Kirin, Inc.$18K
Helsinn Therapeutics (U.S.), Inc.$7K
LEO Pharma Inc.$125
E.r. Squibb & Sons, L.L.C.$82
Pfizer$15
Bausch Health US, LLC$14

$594,325in research payments, 2019–2025

Across 136 payments — averaging $4370.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$480K
Kyowa Kirin Services Ltd$42K
VYNE Pharmaceuticals Inc.$30K
E.r. Squibb & Sons, L.L.C.$18K
Kyowa Kirin Pharmaceutical Development, Inc$11K
AbbVie$10K
plus $2K from 1 others

What the payments were for

Consulting fees$20,48081%
Travel & lodging$3,24013%
Food & beverage$1,3886%
Education$300%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Kyowa Kirin, Inc.	25	$17,512
Helsinn Therapeutics (U.S.), Inc.	11	$7,389
LEO Pharma Inc.	1	$125
E.r. Squibb & Sons, L.L.C.	1	$82
Pfizer	1	$15
Bausch Health US, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

POTELIGEO$16,813
VALCHLOR$7,227
ADBRY$125

How this compares

$25,138 in reported general payments places this provider in the 90th percentile of 263 dermatology providers in Missouri.

See all dermatology providers in Missouri →

Medicare billing

Part B allowed, 2024

$146,423

Medicare patients

613

Services billed

3,031

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	68	$292,040
ValchlorMechlorethamine Hcl	19	$169,483
Dupixent SyringeDupilumab	39	$154,485
Cosentyx Sensoready (2 Pens)Secukinumab	12	$143,962
Bexarotene	63	$105,884
OtezlaApremilast	20	$105,211
RinvoqUpadacitinib	15	$89,427
Clobetasol Propionate	223	$11,400
Acitretin	20	$7,704
Triamcinolone Acetonide	254	$4,206
Clindamycin Phosphate	114	$4,161
Tretinoin	58	$4,155
Tacrolimus	21	$3,451
Ketoconazole	180	$2,713
Metronidazole	60	$2,658

Paid to pharmacies, not to this prescriber.

Other dermatology in Saint Louis

Brian KimSaint Louis$861K
Elaine SiegfriedSaint Louis$856K
Craig LeonardiSaint Louis$569K
Mary GeorgeSaint Louis$400K
Duane DilworthSaint Louis$288K
Jeffrey ReedSaint Louis$170K
Emily ColeSaint Louis$163K
Dee GlaserSaint Louis$131K
Milan AnadkatSaint Louis$129K
Jason AmatoSaint Louis$45K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →